Searchable abstracts of presentations at key conferences in endocrinology

ea0006p9 | Clinical case reports | SFE2003

A RARE CAUSE OF HYPOGLYCAEMIA

Alsafadi H , Ansari H , Biggs P , Randeva H

A 44-year old man, previously well, presented with acute confusion and having collapsed at home. His capillary blood glucose was 2.2mmol/L and he was resuscitated with an intravenous dextrose infusion. His collapse had resulted in a fracture to his right neck of femur.Given the possibility of a pathological fracture he had a bone scan, which revealed widespread bony metastasis. In search for the primary source, an abdominal computerised tomography (CT) s...

ea0006p40 | Endocrine tumours and neoplasia | SFE2003

The effect of pegvisomant therapy on plasma levels of matrix metalloproteinases 2, 9 and vascular endothelial growth factor in patients with acromegaly

Paisley A , Randeva H , Parkinson C , Alsafadi H , Roberts M , Monson J , Drake W , Trainer P

Vascular endothelial growth factor (VEGF) is involved in the activation of the matrix metalloproteinase system (MMP) which in turn degrades the extracellular matrix involved in development, morphogenesis and tissue remodelling. Increased activity of MMPs has been implicated in atherosclerosis and cardiovascular disease. This study assessed plasma MMP and VEGF levels in patients with active acromegaly (IGF-I >130%ULN), and on treatment with pegvisomant.<p class="abstext"...